BioPharma Dive 2026-01-12 JPM26: US biotech’s ‘Sputnik moment,’ Pfizer’s obesity ambitions and Bristol Myers’ big year
FierceBiotech 2026-01-09 Madrigal pays $50M for Pfizer MASH drug with eye on Rezdiffra combo potential
Endpoints News 2026-01-08 French biotech Enodia gets €20.7M aided by Pfizer for protein degrader work
FierceBiotech 2025-12-09 Pfizer continues renewed obesity push with $150M upfront for Fosun unit's GLP-1 drug
Endpoints News 2025-12-05 OTR Therapeutics gets $100M from Pfizer Ventures, others to build asset portfolio
FierceBiotech 2025-12-05 Pfizer Ventures gets behind Chinese biotech's $100M series A to boost R&D hub's capability
Roche Media 2025-12-04 Bio/Pharmaceutical Outsourcing Report, October 2025 - Pfizer and Roche Place $10 Billion Bets on Obesity and Liver Disease Therapies as Trump Tightens Grip on Drug Pricing and Manufacturing - Yahoo Finance
Endpoints News 2025-12-04 Daiichi Sankyo avoids payout in long-running patent dispute with Pfizer’s Seagen
FierceBiotech 2025-12-03 Pfizer-backed Triana scores $120M series B to take molecular glue degrader into clinic
Endpoints News 2025-12-02 Pfizer culls ulcerative colitis candidate; Tiziana to try spinning out IL-6 drug